Skip to main content

Together we are beating cancer

Donate now

Lung Cancer Impact

Currently, only 10% of people with lung cancer will survive their disease for 10 years or more, something we urgently need to address. We have been at the heart of progress in lung cancer for over 50 years. TRACERx is our flagship investment which has unveiled new causes of lung cancer, unlocked potential new ways to diagnose and treat it and fostered the lung cancer research community in the UK.
Showing 7 out of 7 results
Microscopic images of pleural fluid cytology of a small cell oat cell carcinoma
  • Science & Technology
  • Health & Medicine

10 ways we’ve influenced progress in lung cancer

From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 10 ways we have worked towards progress in lung cancer. From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 10 ways we have worked towards progress in lung cancer.

by Amy Warnock | In depth | 1 November 2023

1 November 2023

Prime Minister Rishi Sunak speaks at the 2023 Conservative Party Conference

Ian Walker reflects on Prime Minister Rishi Sunak's announcements on tobacco at the Conservative Party Conference on Wednesday Ian Walker reflects on Prime Minister Rishi Sunak's announcements on tobacco at the Conservative Party Conference on Wednesday

by Ian Walker | Opinion | 6 October 2023

6 October 2023

In one of their recently published papers, TRACERx researchers may have found a new way to track changes in a tumour and see how likely it is to spread, by looking at blood samples.  In one of their recently published papers, TRACERx researchers may have found a new way to track changes in a tumour and see how likely it is to spread, by looking at blood samples. 

by Amy Warnock | Analysis | 1 May 2023

1 May 2023

Non small cell lung cancer cells stained in pleural effusion sample.

Researchers based at the Francis Crick Institute have published new results from TRACERx, revealing the secrets of how lung cancer can evolve, spread and resist treatment. Researchers based at the Francis Crick Institute have published new results from TRACERx, revealing the secrets of how lung cancer can evolve, spread and resist treatment.

by Jacob Smith | Analysis | 12 April 2023

12 April 2023

Left to right: Emma Colliver, Dr William Hill and Dr Emilia Lim

We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today.  We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today. 

by Jacob Smith | Interview | 13 December 2022

13 December 2022

An image of a chest x-ray showing some signs of disease

Up to 14% of people with lung cancer in the UK have never smoked. New research funded by us reveals why non-smokers face delays in getting diagnosed with lung cancer Up to 14% of people with lung cancer in the UK have never smoked. New research funded by us reveals why non-smokers face delays in getting diagnosed with lung cancer

by Jacob Smith | In depth | 25 November 2022

25 November 2022

Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx.  Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx. 

by Kathryn Thompson | News | 9 November 2022

9 November 2022